DOCSLIB.ORG

Meber Diractory

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meber Diractory FOREWORD I t gives me immense pleasure to present first Publication of Pharmexcil Directory of Members. Primary information about our members like name of the Company, Contact details, e-mail, web site and primary business activities are given in the directory. I am sure that this Directory will serve as first hand guide for any overseas buyer. This publication will be distributed free of cost to: G All foreign delegates in all International Pharma Conferences conducted by DINESH B MODY Council Chairman, Pharmexcil G The foreign Buyers in the Buyer-Seller Meetings at abroad and in India organized by Council G The Indian embassies abroad for their reference and to guide the Pharma buyers in the respective countries. G Foreign embassies in India Efforts have been made to make this directory more useful by providing product index as well as members index. However, due to poor response from the members for various mails from the Council to provide the list of products, index for products could not be prepared in the first publication. I am now confident that after observing Councils' positive and transparent approach for the last one and half year to help the Indian Pharma exporters to boost their performance, members will be more responsive in providing the information sought by Council. The Secretariat of the Council has taken all measures to provide correct information about the members, based on available data. However, in case members have any suggestions for improvement, the same may please be brought to the notice of the Council, so that we can improve the next edition of the publication. DINESH B MODY Chairman, Pharmexcil PHARMACEUTICALS EXPORT PROMOTION COUNCIL The Industry (Set up by Ministry of Commerce & Industry, Govt. of India) Indian Pharmaceutical Industry has made phenomenal progress over the years and made its impact in the global market. This sector is being recognized as reliable source for drugs and drug intermediates and formulations. The companies started utilizing the tremendous opportunities available for Indian Pharma industry in post 2005 era to manufacture and export many block buster products getting off-patented. Its immense strength in manufacturing quality medicines at inexpensive prices made the Indian Pharma industry to compete both in regulated and non-regulated markets. This industry is playing a vital role in the Indian economy with about Rs.17000 crores exporting to over 200 countries in the year ear 2004-05. Apart from its strengths in manufacturing and exporting allopathic medicines, India is known for its own systems of medicines with about 7000 units manufacturing various Indian system of medicines viz., Ayurveda, Unani, Siddha, Homeopathy etc. Though strong in cultivation/manufacture of Indian system of medicines, India's share in the global herbal market, estimated at US$ 63 billion, is less than 0.2%, which shows that there is a tremendous scope for export market. Fast growing Biotech industry estimated at about US$ 2 billion market, is yet another part of Indian Pharma industry in India, which has great potential in the international market and needs focused attention to improve its performance in the international market. Separate Council: These above strengths of Indian Pharma industry and the strong and continued recommendations of Four major Pharma associations made the Ministry of Commerce & Industry to realize the need for separate export promotion council. With active support of Govt. of Andhra Pradesh, who provided the necessary corus fund for establishing any new council, Pharmaceutical Export Promotion Council (PHARMEXCIL) has been set up on 12.5.2004. Finally, with its notification No.61 dt. 16.3.2005, Director General of Foreign Trade made Pharmexcil a sole agency to issue RCMCs to all Pharma exporters. Some acknowledged strengths of Indian Pharmaceutical Industry G US$ 8 billion industry G Produces 70% APIs, and almost the entire requirement of formulations within the country th G Ranks 4 in the world, accounting 8% of world production by volume and 2% by value G Very strong in Indian medicine systems of Ayurvedic, Homoepathy, Unani, Siddha and Herbals medicines G Fast growing Biotech industry with US$ 2 billion market G Low cost of production G Low R&D costs G Abundant scientific and technical manpower G Strong intellectual capital G Excellent world-calls national laboratories, specialized in development processes and cost effective technologies G An efficient and cost effective source for procuring generic drugs, especially the drugs going off patent in the next few years G An excellent center for clinical trials G USFDA/WHO complying manufacturing facilities G 15% of Indian Pharmaceutical scientists are in USA, hence good network Categories of products covered under Pharmexcil : Bulk Drugs and its intermediates Diagnostics Formulations Surgicals/Devices Biotech and biological products Neutraceuticals Herbal products Pharma industry related services Medicinal plants Collaborative Research Ayurvedic products Contract manufacturing Unani products Clinical trials and consultancy services Homeopathic medicines Veterinary products The Council The activities of the Council are administered by the Committee of Administration consisting of representatives from various sectors of Pharma Industry. Sri D B Mody of J B Chemicals & Pharmaceuticals Ltd, Mumbai and Sri Venkat Jasti of Suven Life Sciences Ltd, Hyderabad are the Chairman and Vice Chairman of the Council, respectively. The Committee is also represented by four senior officials from govt. of India and Govt. of Andhra Pradesh. The Role of Council : G Issue of RCMC G Organizing Trade delegations/Buyer-Seller Meetings at abroad G Organizing Reverse Buyer-Seller Meetings in India G Assisting members to get their MDA/MAI claims refunded from Govt. of India G Issue of Certificate of Origin G Organizing periodical Seminars/Interactive meetings on exports related issues G Make suggestions to Govt. of India on policy issues relating to Pharma exports G Make representations to Govt. of India and other agencies in India and abroad to get amicable solutions for the common problems of the industry. Pharmexcil Members Directory A. J. NUTRACEUTICALS PVT. LTD. A.MALIK INTERNATIONAL TRADING COMPANY Contact Person : Shri Ajay A.Pendse Contact Person : Shri Roshan Singh Designation : C E O Designation : Partner Contact Address : 10, Usha Sasmira Road, Worli Contact Address : 68/2 Gandhi Gali, 1st Floor, Fatehpuri, Mumbai-400 025. Delhi - 6 Tel : 022-24368631 Tel : 011-23983114 Fax : 022-24379807 Fax : 011-23983115 E-mail : [email protected] E-mail : [email protected] Website : www.ajnutra.com Website : Business Activities : Herbal Extracts & Nutrient Business Activities : Pharmaceutical Formulations Products AACASH EXPORTS AADIVIGNESH CHEM PVT LTD Contact Person : Shri Rajiv Rammohan K Contact Person : Shri Amish B. Shah Designation : Partner Designation : Director Contact Address : B-14,krishna Leela Chs Ltd, Contact Address : 7/A, Badrinath Apt., Shimpoli Rd, Bangur Nagar, Goregaon(E), Borivali (E), Mumbai Mumbai-400090 Tel : 28338365 Tel : 022 28724258 / 28722581 Fax : 28980051 /28747930 E-mail : [email protected] Fax : 022-28729918 Website : E-mail : [email protected] Business Activities : Bulk Drugs & Drug Intermediates, Website : www.aacash.com/ Herbal Products & Allied Products Business Activities : Drugs & Drug Intermediates AAREY DRUGS & PHARMACEUTICALS LTD AARON PHARMACEUTICALS PVT LTD Contact Person : Contact Person : Shri Rajesh P Ghatalia Shri Raju Sharma Designation : Designation : Director Managing Director Contact Address : Contact Address : 107, Sahakar Industry House, Mahakali Road, Bhavan, 340/48, N.N. Street, Masjid, Andheri (E), Mumbai - 93 Tel : 022-26874863 Mumbai-400009 Fax : Tel : 022-23400521/657/23435182/3425486 022-26874863 Fax : E-mail : [email protected] 022-26103545/2325478 Website : E-mail : [email protected] Website : Business Activities : Pharmaceutical Formulations Business Activities : Bulk Drugs & Drug Intermediates AARTI DRUGS LIMITED AARSHA CHEMICALS PVT LTD Contact Person : Prakash M. Patil Contact Person : Shri. T V Vijayaraghavan Designation : Managing Director Designation : Director Contact Address : Mahendra Indl. Estate, 2nd Floor, Contact Address : 17/27,midc Taloja , Indl.Area Taloja, Plot No. 109-D, Sion (E), Dist. Raigad, Maharashtra-410208 Mumbai-400022 Tel : 27412467/25418281 Tel : 24072249 / 5 LINES Fax : 25426466 Fax : 24073462 / 144 E-mail : [email protected] E-mail : [email protected] Website : Website : www.aartidrugs.com Business Activities : Pharmaceutical Formulations, Health Business Activities : Drugs & Drug Intermediates, Formulations, Fine Care Services. Chemicals, Eyes & Intermediates website : www.pharmexcil.com 1 e-mail : [email protected] Pharmexcil Members Directory AARTI INDUSTRIES LTD ABHYUDAY INDUSTRIES Contact Person : Shri R.C.Gogri Contact Person : Shri Praful Manilal Mehta Designation : Director Designation : Partner Contact Address : Udyog Kshetra, 2nd Floor, Mulund Contact Address : 27, Market Yard, Po Box No : 6, Goregaon Link Road, Mulund (W), Sidhpur, Gujarat-384151 Mumbai - 80 Tel : 02767-220534/220529 Tel : 55976666 Fax : 02767-221034 Fax : 25653185 E-mail : [email protected] E-mail [email protected] Website : Website : www.aartidrugs.com Business Activities : Psyllium Seed & Powder Business Activities : Bulk Drugs & Drug Intermediates, Formulations, Fine Chemicals, Dyes & Dyes Intermediates. AASTRID INTERNATIONAL PVT. LTD ABIL CHEMPHARMA
Load more

Recommended publications
  • High Court of Delhi Advance Cause List
    HIGH COURT OF DELHI ADVANCE CAUSE LIST LIST OF BUSINESS FOR th THURSDAY, THE 04 APRIL, 2019 INDEX PAGES 1. APPELLATE JURISDICTION 01 TO 64 2. COMPANY JURISDICTION 65 TO 68 3. ORIGINAL JURISDICTION 69 TO 80 4. REGISTRAR GENERAL/ 81 TO 93 REGISTRAR(ORGL.)/ REGISTRAR (ADMN.)/ JOINT REGISTRARS(ORGL). 04.04.2019 1 (APPELLATE JURISDICTION) 04.04.2019 [Note : Unless otherwise specified, before all appellate side courts, fresh matters shown in the supplementary lists will be taken up first.] COURT NO. 1 HON'BLE THE CHIEF JUSTICE HON'BLE MR. JUSTICE V.KAMESWAR RAO AFTER NOTICE MISC. MATTERS FOR FINAL HEARING (CONNECTED MATTERS)/ PH / AT 2.15 P.M. ____________________________________________________________________________________ 1. W.P.(C) 4091/2017 BHARTI TELEMEDIA LIMITED & HARSH KAUSHIK & ABHAY CM APPL. 17956/2017 ANR CHATTOPADHYAY,SAKET WITH W.P.(C) 4135/2017 Vs. TELECOM REGULATORY SINGH,SNDEEP S LADDA AND W.P.(C) 6915/2017 AUTHORITY OF INDIA YASHVARDHAN,KIRTIMAN SINGH W.P.(C) 7017/2017 2. W.P.(C) 4135/2017 TATA SKY LTD. & ANR RISHI AGRAWALA FOR AGARWAL CM APPL. 18080/2017 Vs. TELECOM REGULATORY LAW ASSOCIATES,ARJUN CM APPL. 28307/2018 AUTHORITY OF INDIA & ANR NATARAJAN,ARJUN CM APPL. 28308/2018 NATARJAN,SNDEEP S LADDA AND CM APPL. 10147/2019 YASHVARDHAN,VIKAS CM APPL. 14592/2019 MAHAJAN,AUJUN NATARAJAN 3. W.P.(C) 6915/2017 DISCOVERY COMMUNICATION INDIA M/S AZB & PARTNERS,NEETI CM APPL. 28712/2017 & ANR NIYAMAN,V P SINGH,KIRTIMAN CM APPL. 28306/2018 Vs. TELECOM REGULARTORY SINGH,ARJUN NATARAJAN CM APPL. 11325/2019 AUTHORITY OF INDIA 4. W.P.(C) 7017/2017 TARUN MEHTA TUSHAR SINGH,KIRTIMAN CM APPL.
    [Show full text]
  • Aloe Ferox 117 Table 9: Phytochemical Constituents of Different Extracts of Aloe CIM- Sheetal Leaves 119
    International Journal of Scientific & Engineering Research ISSN 2229-5518 1 Morphological, in vitro, Biochemical and Genetic Diversity Studies in Aloe species THESIS SUBMITTED TO OSMANIA UNIVERSITY FOR THE AWARD OF DOCTOR OF PHILOSOPHY IN GENETICS IJSER By B. CHANDRA SEKHAR SINGH DEPARTMENT OF GENETICS OSMANIA UNIVERSITY HYDERABAD - 500007, INDIA JULY, 2015 IJSER © 2018 http://www.ijser.org International Journal of Scientific & Engineering Research ISSN 2229-5518 2 DECLARATION The investigation incorporated in the thesis entitled “Morphological, in vitro, Biochemical and Genetic Diversity Studies in Aloe species’’ was carried out by me at the Department of Genetics, Osmania University, Hyderabad, India under the supervision of Prof. Anupalli Roja Rani, Osmania University, Hyderabad, India. I hereby declare that the work is original and no part of the thesis has been submitted for the award of any other degree or diploma prior to this date. IJSER Date: (Bhaludra Chandra Sekhar Singh) IJSER © 2018 http://www.ijser.org International Journal of Scientific & Engineering Research ISSN 2229-5518 3 DEDICATION I dedicateIJSER this work to my beloved and beautiful wife B. Ananda Sekhar IJSER © 2018 http://www.ijser.org International Journal of Scientific & Engineering Research ISSN 2229-5518 4 Acknowledgements This dissertation is an outcome of direct and indirect contribution of many people, which supplemented my own humble efforts. I like this opportunity to mention specifically some of them and extend my gratefulness to other well wisher, known and unknown. I feel extremely privileged to express my veneration for my superviosor Dr. Anupalli Roja Rani, Professor and Head, Department of Genetics, Osmania University, Hyderabad. Her whole- hearted co-operation, inspiration and encouragement rendered throughout made this in carrying out the research and writing of this thesis possible.
    [Show full text]
  • International Registration Designating India Trade Marks Journal No: 1835 , 05/02/2018 Class 1
    International Registration designating India Trade Marks Journal No: 1835 , 05/02/2018 Class 1 Priority claimed from 19/11/2015; Application No. : 014818769 ;European Union 3391941 12/04/2016 [International Registration No. : 1307170] GELITA AG Uferstr. 7 69412 Eberbach Germany Address for service in India/Attorney address: LALL & SETHI D-17, N.D.S.E.-II NEW DELHI-49 Proposed to be Used IR DIVISION Chemicals for industrial purposes; gelatine for industrial purposes; gelatine hydrolysate [raw material] for industrial use and for the preparation of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products, dietary products and nutritional supplements; protein [raw material]. 8456 Trade Marks Journal No: 1835 , 05/02/2018 Class 1 Priority claimed from 17/10/2016; Application No. : 1341145 ;Benelux 3518971 18/11/2016 [International Registration No. : 1330622] STAHL INTERNATIONAL B.V. Sluisweg 10 NL-5145 PE WAALWIJK Proposed to be Used IR DIVISION Chemicals for industry purposes, including leather, processing of leather, textile, floor, tapestry, improvement and furniture industries; synthetic resins and synthetic resins including chemical additives wanted by processing of these resins; plastics as raw materials in powder, liquid or paste form; tempering preparations, tanning substances, adhesives for industrial purposes; oils for tanning leather; all the aforementioned goods being products used in the leather processing industry in order to make lightweight leather. 8457 Trade Marks Journal No: 1835 , 05/02/2018 Class 1 Priority
    [Show full text]
  • High Court of Delhi Advance Cause List
    HIGH COURT OF DELHI ADVANCE CAUSE LIST LIST OF BUSINESS FOR TH THURSDAY, THE 13 DECEMBER, 2018 INDEX PAGES 1. APPELLATE JURISDICTION 01 TO 56 2. COMPANY JURISDICTION 57 TO 64 3. ORIGINAL JURISDICTION 65 TO 78 4. REGISTRAR GENERAL/ 79 TO 91 REGISTRAR(ORGL.)/ REGISTRAR (ADMN.)/ JOINT REGISTRARS(ORGL). 13.12.2018 1 (APPELLATE JURISDICTION) 13.12.2018 [Note : Unless otherwise specified, before all appellate side courts, fresh matters shown in the supplementary lists will be taken up first.] COURT NO. 1 (DIVISION BENCH-I) HON'BLE THE CHIEF JUSTICE HON'BLE MR. JUSTICE V. KAMESWAR RAO FOR ADMISSION _______________ 1. W.P.(C) 7083/2018 DANIEL GEORGE DEHADRAI AND CO,SANGEETA CM APPL. 26927/2018 Vs. GOVERNMENT OF NCT OF CHANDRA,SANJOY GHOSE DELHI & ORS. AFTER NOTICE MISC. MATTERS ____________________________ 2. LPA 9/2018 MANOHAR SINGH IN PERSON,SL GUPTA,ABHA CM APPL. 29015/2018 Vs. STATE BANK OF INDIA & MALHOTRA ANR 3. LPA 495/2018 RAJEEV NEELU KACHWAHA RAGHAVENDERA M CM APPL. 34970/2018 CHARITABLE TRUST (NGO-SWATI) BAJAJ,PARVINDER CM APPL. 44626/2018 Vs. DELHI URBAN SHELTER CHAUHAN,ZUBEDA BEGUM,RIPU IMPROVEMENT BOARD & ORS DAMAN BHARDWAJ 4. LPA 507/2018 ARCELORMITTAL INDIA PVT LTD & ASHIHS RANA,CHANDRA BHUSHAN CM APPL. 35803/2018 ANR PRASAD,AMIT MAHAJAN Vs. UNION OF INDIA & ORS 5. W.P.(C) 8477/2014 PUNJAB & SIND BANK R.V. ASSOCIATES,DILPREET Vs. TEJWANT SINGH & ORS SINGH 6. W.P.(C) 8490/2015 CENTRAL BANK OF INDIA SATYA DEV SHARMA & CO. Vs. PRITPAL KAUR & ORS 7. W.P.(C) 9301/2015 M/S BEDI PLASTIC INDUSTRIES ABHAY CHAUHAN,VINAY SHARMA CM APPL.
    [Show full text]
  • International Registration Designating India Trade Marks Journal No: 1960 , 10/08/2020 Class 1
    International Registration designating India Trade Marks Journal No: 1960 , 10/08/2020 Class 1 Priority claimed from 07/10/2019; Application No. : 88644417 ;United States of America 4513772 31/03/2020 [International Registration No. : 1528222] Thermo Fisher Scientific (Bremen) GmbH Hanna-Kunath-Strasse 11 28199 Bremen Germany Proposed to be Used IR DIVISION Kits comprised of enzymes, reagents, nucleotides, and assays for scientific or research purposes. 6449 Trade Marks Journal No: 1960 , 10/08/2020 Class 1 4534058 24/03/2020 [International Registration No. : 1468883] Evonik Operations GmbH Rellinghauser Str. 1 - 11 45128 Essen Germany Proposed to be Used IR DIVISION Cl.1;Chemical substances, chemical materials and chemical preparations, and natural elements, included in this class, for use in industry; detergents for use in manufacture and industry; filtering media of chemical and non-chemical substances included in this class. 6450 Trade Marks Journal No: 1960 , 10/08/2020 Class 1 Priority claimed from 30/10/2019; Application No. : 2019-138709 ;Japan 4535241 31/03/2020 [International Registration No. : 1535335] Sanyo Chemical Industries, Ltd. 11-1, Ikkyo Nomoto-cho, Higashiyama-ku, Kyoto-shi Kyoto 605-0995 Japan Proposed to be Used IR DIVISION Industrial chemicals; surface-active chemical agents; chemical additives for fuel; chemical additives for lubricating oils; chemical additives improving the viscosity index of lubricating oil; plasticizers; chemical preparations for metal finishing; antibacterial agents for industrial use; resin
    [Show full text]
  • Inception Report
    To Study the Cultivation /Collection Practices and Market Analysis of Ashwagandha, Aloe-vera and Aonla in the State of Telangana @2020 Research Team Dr. Sattram Singh, Principal Investigator Ms. Dyuti De, Consultant July, 2020 Printed at: Tituprint F-58, Malviya Industrial Area, Jaipur, Rajasthan-302017. Prepared By: CCS NATIONAL INSTITUTE OF AGRICULTURAL MARKETING (An Autonomous Organization of Ministry of Agriculture and Farmers’ Welfare, Government of India) Kota Raod, Bambala, Pratap Nagar, Jaipur-302033, Rajasthan www.ccsniam.gov.in ACKNOWLEDGEMENTS The idea of conducting the present study entitled “To Study the Cultivation /Collection Practices and Market Analysis of Ashwagandha, Aloe-vera and Aonla in the State of Telangana” coined in the Annual Board Meeting held in the NMPB office at New Delhi in the month of August, 2017. The meeting chaired by Ms. Shomita Biswas, IFS, the then Chief Executive Officer, NMPB and Ms. Irina Garg, IRS, the then Director General, CCS NIAM and undersigned attended the meeting to explore the opportunity for consultancy project. The representative of others states were also attended the meeting. In consequence of the discussion in the meeting the proposal for conducting the present study coined by Ms. Sonibala Akoijam, IFS, CEO Telangana Medicinal Plants Board. After that a research outline emerged through a discussion with respective state. On behalf of CCS NIAM, I would like to thank Dr. P. Chandra Shekara, Director General, CCS NIAM for constant help and encouragement time to time during the study and also provide all kind of freedom in conducting the study and continuous support to bring the study to a logical conclusion.
    [Show full text]
  • NOTICE in VIEW of the ENSUING LOCAL HOLIDAYS, FRESH MATTERS and APPLICATIONS WILL ALSO BE LISTED on THURSDAY, the 01St NOVEMBER, 2018
    01.11.2018 SUPPLEMENTARY LIST SUPPLEMENTARY LIST FOR TODAY IN CONTINUATION OF THE ADVANCE LIST ALREADY CIRCULATED. THE WEBSITE OF DELHI HIGH COURT IS www.delhihighcourt.nic.in INDEX PRONOUNCEMENT OF JUDGMENTS -----------------> 01 TO 01 REGULAR MATTERS ----------------------------> 01 TO 96 FINAL MATTERS (ORIGINAL SIDE) --------------> 01 TO 12 ADVANCE LIST -------------------------------> 01 TO 114 APPELLATE SIDE (SUPPLEMENTARY LIST)---------> 115 TO 132 APPELLATE SIDE (SUPPLEMENTARY LIST-MID)-----> 133 TO 149 ORIGINAL SIDE (SUPPLEMENTARY I)-------------> 150 TO 157 COMPANY ------------------------------------> 158 TO 158 SECOND SUPPLEMENTARY -----------------------> 159 TO 170 THIRD SUPPLEMENTARY -----------------------> 171 TO 171 MEDIATION CAUSE LIST -----------------------> 01 TO 02 PRE-LOK ADALAT------------------------------> 01 TO 02 NOTE 1. Mentioning of urgent matters will be before Hon'ble DB-I at 10.30 A.M.. NOTICE IN VIEW OF THE ENSUING LOCAL HOLIDAYS, FRESH MATTERS AND APPLICATIONS WILL ALSO BE LISTED ON THURSDAY, THE 01st NOVEMBER, 2018. DELETIONS 1. BAIL APPL. 2074/2018 listed before Hon'ble DB-I at item No.4 is deleted. 2. LPA 280/2018 listed before Hon'ble DB-V at item No.1 is deleted. CORRIGENDUM 1. MAT.APP.(F.C.) 188/2018 listed before Hon'ble DB-IV at item No.12 may be read as under: 12. MAT.APP.(F.C.) 188/2018 ANURADHA V IYER AVNISH KUAMR SHARMA CM APPL. 31596/2018 Vs. VINAY RAMACHANDRAN IYER As approved by Hon'ble Chairman, DHCLSC, National Lok Adalat is to be held on 08.12.2018(SECOND SATURDAY) at High Court of Delhi for the pending cases under following category:- 1. Criminal Compoundable Offence 2. NI Act cases under Section 138; 3.
    [Show full text]
  • Trade Marks Journal No: 1963 , 31/08/2020
    Trade Marks Journal No: 1963 , 31/08/2020 022-24148251 022-24101144 022-24101177 Fax No.022-24140408 भारत सरकार वािणय और उयोग मंत्रालय Website: http://ipindia.nic.in Patents/Designs/Trademark यापार िचह रिजट्री Geographical Indications बौिद्धक संपदा भवन, एस.एम. रोड, एटॉप िहल, मुंबई 400037 GOVERNMENT OF INDIA Ministry of Commerce & Industries TRADE MARKS REGISTRY Boudhik Sampada Bhawan, S. M. Road, Antop Hill, Mumbai 400037 CG Office/Notice/2020/ dated: 31/08/2020 Notice It is bring to the notice of anyone concern that Trade Marks Journal No. 1940 dated 10/02/2020 published 8204 trademarks and Trade Marks Journal No. 1941 dated 17/02/2020 published 7838 trademarks inviting opposition from the public, if any, within 4 months time from the date of publication as per provision of the law. It may be further noted that 1278 marks are opposed under TM Journal No. 1940 and 1196 trademarks are opposed under TM Journal No. 1941. The Trade Marks Registry did not receive any communication relating to any opposition / objection in regard to 13582 trademarks till 28 August, 2020 (details attached). If anyone has submitted any communication in respect of these published marks then same may be brought to attention of this office. Sd/- Controller General of Patent, Design and Trade Marks 9317 Trade Marks Journal No: 1963 , 31/08/2020 Trade Mark Journal No. 1940: published dated 10/02/2020 Trade Mark Journal No. 1941: published dated 17/02/2020 Sr. Application Application Class Journal Proprietor Name No.
    [Show full text]
  • Agenda Natev2018 5Th
    Healthcare Federation of India (NATHEALTH) 5thNATHEALTH Annual Event NATEv2018 Venue: Ball Room, 1st Floor, Shangri-La's-Eros Hotel, New Delhi Day and Date: Friday 16th March 2018 Event Partners Principal Media Partner Knowledge Partner Concept Partners ‘Reinvent-->Empower-->Heal’ 08.30 am to 10.00 am -Registration & Networking Tea 10.00 am to 11.00 am “Inaugural session” NATHEALTH Audio-Visual - Our Journey so far and way ahead Welcome address by Mr. Sushobhan Dasgupta NATHEALTH Update by President, NATHEALTH (Honorary) Brig. Dr. Arvind Lal Chief Guest Address Minister of State (Health)* Vote of Thanks by Secretary General, NATHEALTH Mr. Anjan Bose 11.00 am to 11:15 am Networking & Fellowship tea/coffee 11.15 am to 12.15 pm “Top clinicians: Concerns and Challenges in today’s Healthcare” Moderator: Mr. Parijat Ghosh, Partner, Bain & Co. (Knowledge Today there is significant trust deficit between patients/ Partner of NATHEALTH) families and healthcare professionals. This is against a backdrop of easily accessible, even if questionable, information about diseases and treatment methods online Panelists: and some high profile and publicised missteps by Dr. Ashok Rajgopal professionals. This leads to a number of critical aspects Dr. Pradeep Chowbey around informed consent, the cost and efficacy of different Dr. BK Rao treatment paths/ choices, time starved professionals and Dr. Smita Sharma (credible) information starved patients, medical liability Dr. Jacob Chacko Korula and how these need to come together for a productive Dr. Yash Gulat relationship between the healthcare professional and the patient/ family. This session on ‘Top Clinicians’ is perfectly aligned with our theme ‘Heal’ as it focuses on enhancing quality, access and affordability of healthcare services in India.
    [Show full text]
  • 1919, 16/09/2019 P`Kasana : Baart Sarkar Vyaapar Icanh Rijast/I P`
    Trade Marks Journal No: 1919, 16/09/2019 Reg. No. TECH/47-714/MBI/2000 Registered as News Paper p`kaSana : Baart sarkar vyaapar icanh rijasT/I esa.ema.raoD eMTa^p ihla ko pasa paosT Aa^ifsa ko pasa vaDalaa mauMba[mauMba[---- 400037 durBaaYa : 022 24101144 ,24101177 ,24148251 ,24112211. Published by: The Government of India, Office of The Trade Marks Registry, Baudhik Sampada Bhavan (I.P. Bhavan) Near Antop Hill, Head Post Office, S.M. Road, Mumbai-400037. Tel: 022 24101144, 24101177, 24148251, 24112211. 1 Trade Marks Journal No: 1919, 16/09/2019 Anauk/maiNaka INDEX AiQakairk saucanaaeM Official Notes vyaapar icanh rijasT/IkrNa kayaakayaa----layalaya ka AiQakar xao~ Jurisdiction of Offices of the Trade Marks Registry sauiBannata ko baaro maoM rijrijaYT/araYT/ar kao p`arMiBak salaahsalaah AaoOr Kaoja ko ilayao iinavaodnanavaodna Preliminary advice by Registrar as to distinctiveness and request for search saMbaw icanh Associated Marks ivaraoQa Opposition ivaiQak p`maaNa p`p`~~ iT.ema.46 pr AnauraoQa Legal Certificate/ Request on Form TM-46 k^apIra[T p`maaNa p`~ Copyright Certificate t%kala kayakaya---- Operation Tatkal saavasaava----jainakjainak saucanaaeM Public Notices iva&aipt Aavaodna Applications advertised class-wise: 2 Trade Marks Journal No: 1919, 16/09/2019 vaga- / Class - 1 11-94 vaga- / Class - 2 95-130 vaga- / Class - 3 131-363 vaga- / Class - 4 364-388 vaga- / Class - 5 389-1225 vaga- / Class - 6 1226-1312 vaga- / Class - 7 1313-1479 vaga- / Class - 8 1480-1510 vaga- / Class - 9 1511-1866 vaga- / Class - 10 1867-1928 vaga- /
    [Show full text]
  • Natev 2018 Edition
    Presents A special NATEv 2018 edition MINISTRY OF HEALTH NATEv 2018 & FAMILY WELFARE 5th Annual Event of NATHEALTH Reinvent-->Empower-->Heal Ball Room, 1st Floor, Shangri-La’s-Eros Hotel, New Delhi 16th March 2018 Industry Voices Inside the Sessions Speakers Dr. Harsh Mahajan | Mr. Gautam Khanna | Chosen panelists give an insight A listing of all the speakers Dr. Shakti Gupta | Dr. Shravan Subramanyam | into the relevance of various participating in NATEv 2018 with a quick look | Probir Das | sessions at the event into their profiles Opening Note by The President’s Word An in-depth interview with (Brig.) Dr. Arvind Lal, Mr. Anjan Bose, Secretary General - NATHEALTH President - NATHEALTH 1.15pm to 2.00 pm Fellowship Lunch AGENDA 2.00 pm to 2.45 pm “Medical Tourism” Medical Value Travel/Medical Tourism: An unfulfilled potential for India Moderator: Ms. Charu Sehgal Some Relevant Points Heads the Strategy and Operations 08.30 am to 10.00 am -Registration & Networking Tea • Medical tourism globally is a US$17 billion market and is expected to Consulting practice at Deloitte India cross US$40 billion by and is the National Leader for the Life 10.00 am to 11.00 am “Inaugural session” 2020. Sciences and Healthcare Vertical. • CAGR-17% . (Concept Partner- NATHEALTH) NATHEALTH Audio-Visual - Our Journey so far and way ahead • India along with countries like Thailand, Malaysia, Singapore, Mexico etc. plays a key role in Guest of Honour: Ms. Rashmi Verma*, Welcome address by Mr. Sushobhan Dasgupta shaping this market opportunity. Hon. Secretary, Ministry of Tourism, Gov- NATHEALTH Update by President, (Honorary) Brig.
    [Show full text]
  • Consensus Statement of Padma Awardee Doctors' Forum Regarding
    CONSENSUS STATEMENT (Padma Awardee Doctors' Forum) Indian Journal of Clinical Practice, Vol. 30, No. 4, September 2019 Consensus Statement of Padma Awardee Doctors’ Forum Regarding Exclusion of Medical Professionals from the Consumer Protection Act India International Centre (IIC), New Delhi | August 28, 2019 KK AGGARWAL, AK BHALLA, AK GROVER, ANOOP MISRA, ARVIND LAL, AS SOIN, ASHOK SETH, BN SAHI, DS GAMBHIR, GANESH MANI, GK KHATRI, HARSH MAHAJAN, KALYAN BANERJEE, KK SETHI, KK TALWAR, M KHALILULLAH, M WALI, MADAN MOHAN, MAHESH VERMA, MALVIKA SABHARWAL, NEELAM KLER, NIKHIL TANDON, NITISH NAIK, NK PANDEY, NM SHROFF, NP GUPTA, P LAL, P VENUGOPAL, RAMAN KAPOOR, RANDHIR SUD, RK GROVER, SANJEEV BAGAI, SAUMITRA RAWAT, SC MANCHANDA, TS KLER, UPENDRA KAUL, YASH GULATI he Consumer Protection Bill, 1986 was passed by CONSUMER PROTECTION ACT, 2019 both the Houses of Parliament and it received the assent of the President on 24th December 1986. The Consumer Protection Bill, 2019 has been passed T by both Houses of Parliament i.e. Lok Sabha (30th It came on the Statutes Book as The Consumer Protection Act, 1986 (68 of 1986). The Legislature while July 2019) and Rajya Sabha (6th August 2019). Thus, drafting the Bill, 1986 had specifically not included the a new law on consumer protection has been enacted services provided by the medical professionals in the i.e. the Consumer Protection Act, 2019. The new term of services. Also, there is no mention of medical act does not include services rendered by medical professionals, doctors, etc., anyplace in the Consumer professionals. Protection Act, 1986. Earlier, when amendments to the Consumer Protection The fact that there is a distinction between a profession Act were introduced in 2015, there was no mention and an occupation was the main reason for not of “health care” in the list of examples of as to including the medical professionals under the purview what constitutes “service”.
    [Show full text]